Skip to main content
. 2013 Feb 13;10(5):770–778. doi: 10.4161/rna.23876

Table 2. Plasmid yields and stability (see also Figs. 1 and 2). Cells were grown as overnight cultures for extraction of pUC19-based ColE1 plasmids, or pRSF or p15A non-ColE1 plasmids, expressing Cas3 or Cascade as indicated.

E. coli strain Plasmid Plasmid concentration (ng/µl)a) OD600 Viability cells per ml (×107)c) AmpR, KanR or ChlmR cells
(% total)b)
MG1655
pUC19
68.4 (± 22.5)
1.3 (± 0.02)
154 (± 22)
100.0
pCas3+
261.3 (± 17.0)
2.0 (± 0.07)
123 (± 32)
94.0
pCas3K320L
72.9 (± 3.4)
2.3 (± 0.01)
109 (± 3)
95.5
 
pCas3K78L
221.8 (± 43.0)
1.4 (± 0.17)
78.5 (± 23)
5.3
 
pCascade
25.6 (± 4.4)
1.9 (± 0.13)
173(± 7)
0.1
 
pCasC
30.8 (± 1.3)
1.5 (± 0.12)
72.5(± 33)
5.0
BL21 AI
pRSF1b
112.7 (± 4.6)
1.4 (± 0.05)
70 (± 10)
89.7
 
pCas3-RSF (arabinose)
139.0 (± 21.8)
1.1 (± 0.12)
32.5 (± 5)
85.7
 
pCas3-RSF (glucose)
144.5 (± 26.0)
1.5 (± 0.15)
77.5 (± 20)
100
MG1655 araB
T7 RNAP
pACYCDuet-1
pCas3-pACYC
(arabinose)
pCas3-pACYC
(glucose)
29.5 (± 2.8)
29.5 (± 2.8)
39.75 (± 11.7)
1.7 (± 0.01)
1.46 (± 0.04)
1.75 (± 0.05)
115 (± 35)
65 (± 7)
115 (± 21)
100
100
100
EB304 (Δcas3)
pCascade
25.4(± 4.0)
0.94 (± 0.2)
190 (± 16)
1.0
  pUC19 47.66(± 7.0) 2.0 (± 0.02) 147 (± 10) 100.0

a)Plasmid concentrations were measured in a Nanovue spectrophotometer (GE Healthcare). Values are means of three independent experiments with standard deviations given in parentheses. b)The percentage cells retaining plasmid was measured by comparing viable colony counts after plating on agar with, or without ampicillin or appropriate antibiotic. c)Viable cell number was from counting colonies after plating 100 µl of serially diluted bacteria on LB agar plates from at least two independent experiments.